JP2024513538A5 - - Google Patents
Info
- Publication number
- JP2024513538A5 JP2024513538A5 JP2024505487A JP2024505487A JP2024513538A5 JP 2024513538 A5 JP2024513538 A5 JP 2024513538A5 JP 2024505487 A JP2024505487 A JP 2024505487A JP 2024505487 A JP2024505487 A JP 2024505487A JP 2024513538 A5 JP2024513538 A5 JP 2024513538A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- piperazine
- ethyl
- dioxo
- tetrahydroquinazoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110392892 | 2021-04-12 | ||
| CN202110392892.4 | 2021-04-12 | ||
| CN202110707739.6 | 2021-06-24 | ||
| CN202110707739 | 2021-06-24 | ||
| CN202111065912 | 2021-09-10 | ||
| CN202111065912.3 | 2021-09-10 | ||
| PCT/CN2022/086311 WO2022218296A1 (en) | 2021-04-12 | 2022-04-12 | Substituted fused bicyclic compounds as parp inhibitors and the use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513538A JP2024513538A (ja) | 2024-03-25 |
| JP2024513538A5 true JP2024513538A5 (https=) | 2025-05-08 |
Family
ID=83640149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505487A Pending JP2024513538A (ja) | 2021-04-12 | 2022-04-12 | Ｐａｒｐ阻害剤としての置換融合二環式化合物及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240208969A1 (https=) |
| EP (1) | EP4326713A4 (https=) |
| JP (1) | JP2024513538A (https=) |
| KR (1) | KR20240009929A (https=) |
| CN (3) | CN117653636B (https=) |
| CA (1) | CA3216489A1 (https=) |
| MX (1) | MX2023012039A (https=) |
| WO (1) | WO2022218296A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024050370A1 (en) * | 2022-08-30 | 2024-03-07 | 1Cbio, Inc. | Heterocyclic compounds and methods of use thereof |
| KR20250103668A (ko) * | 2022-11-10 | 2025-07-07 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | 축합 이환 화합물 |
| TW202506680A (zh) * | 2023-04-28 | 2025-02-16 | 美商思諾維新醫藥公司 | 作為ｐａｒｐ１抑制劑之雜環化合物 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998018781A2 (en) * | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents |
| JP2001302515A (ja) * | 2000-04-18 | 2001-10-31 | Sumitomo Pharmaceut Co Ltd | ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤 |
| JP2002284699A (ja) * | 2001-03-28 | 2002-10-03 | Sumitomo Pharmaceut Co Ltd | 視細胞変性疾患治療剤 |
| CN1918151A (zh) * | 2003-12-19 | 2007-02-21 | 伊莱利利公司 | 三环甾类激素核受体调节剂 |
| EA011552B1 (ru) * | 2004-06-30 | 2009-04-28 | Янссен Фармацевтика Н.В. | Производные хиназолиндиона в качестве ингибиторов parp |
| MX2007010068A (es) * | 2005-02-16 | 2007-10-10 | Schering Corp | Piperazino-piperidinas con actividad antagonista de cxcr3. |
| JP2007137818A (ja) * | 2005-11-17 | 2007-06-07 | Taisho Pharmaceut Co Ltd | ８−ヒドロキシ−２，４（１ｈ，３ｈ）−キナゾリンジオン誘導体 |
| US8404713B2 (en) * | 2007-10-26 | 2013-03-26 | Janssen Pharmaceutica Nv | Quinolinone derivatives as PARP inhibitors |
| WO2009086303A2 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| ES2367760T3 (es) * | 2008-03-27 | 2011-11-08 | Janssen Pharmaceutica, N.V. | Derivados de quinazolinona como inhibidores de la polimerización de la tubulina. |
| JP5744019B2 (ja) * | 2009-07-14 | 2015-07-01 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | 選択的ｐａｒｐ−１阻害を有する３−オキソ−２，３−ジヒドロ−１ｈ−イソインドール−４−カルボキサミド |
| WO2011021678A1 (ja) * | 2009-08-21 | 2011-02-24 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| JP2012184205A (ja) * | 2011-03-08 | 2012-09-27 | Dainippon Sumitomo Pharma Co Ltd | ２−アミノ置換８−オキソジヒドロプリン誘導体 |
| CA2829123C (en) * | 2011-03-14 | 2016-04-12 | Eternity Bioscience Inc. | Quinazolinediones and their use |
| CN102731416A (zh) * | 2011-04-01 | 2012-10-17 | 南京英派药业有限公司 | 1-(芳基甲基)-喹唑啉-2，4-二酮作为parp抑制剂及其应用 |
| TWI527800B (zh) * | 2011-04-01 | 2016-04-01 | 南京英派藥業有限公司 | 作為聚（二磷酸腺苷酸－核醣）聚合酶（ｐａｒｐ）之抑制劑之１－（芳基甲基）喹唑啉－２，４（１ｈ，３ｈ）－二酮及其應用 |
| EP2913330A1 (en) * | 2014-02-27 | 2015-09-02 | Laboratoire Biodim | Condensed derivatives of imidazole useful as pharmaceuticals |
| CN104892589A (zh) * | 2014-03-07 | 2015-09-09 | 中国科学院上海药物研究所 | 一类杂环化合物、其制备方法和用途 |
| CN109563051B (zh) * | 2016-08-22 | 2024-06-11 | 南京明德新药研发有限公司 | 作为pde4抑制剂的并环类化合物 |
| AU2017317123B9 (en) * | 2016-08-22 | 2021-11-25 | Medshine Discovery Inc. | PDE4 inhibitor |
| WO2018112842A1 (en) * | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor |
| WO2018165615A1 (en) * | 2017-03-09 | 2018-09-13 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Parp-1 and methods of use thereof |
| SI3999506T1 (sl) * | 2019-07-19 | 2025-06-30 | Astrazeneca Ab | Zaviralci PARP1 |
-
2022
- 2022-04-12 EP EP22787519.2A patent/EP4326713A4/en active Pending
- 2022-04-12 US US18/554,980 patent/US20240208969A1/en active Pending
- 2022-04-12 KR KR1020237037924A patent/KR20240009929A/ko active Pending
- 2022-04-12 WO PCT/CN2022/086311 patent/WO2022218296A1/en not_active Ceased
- 2022-04-12 CN CN202311660486.7A patent/CN117653636B/zh active Active
- 2022-04-12 CN CN202280011128.0A patent/CN116783181B/zh active Active
- 2022-04-12 CN CN202610252591.4A patent/CN121800782A/zh active Pending
- 2022-04-12 JP JP2024505487A patent/JP2024513538A/ja active Pending
- 2022-04-12 MX MX2023012039A patent/MX2023012039A/es unknown
- 2022-04-12 CA CA3216489A patent/CA3216489A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024531477A5 (https=) | ||
| EP3288558B1 (en) | Combinations of inhibitors of irak4 with inhibitors of btk | |
| JP2024513538A5 (https=) | ||
| ES2921875T3 (es) | Combinaciones terapéuticas de un inhibidor BTK, un inhibidor PD-1 y/o un inhibidor PD-L1 | |
| AU2021202875B2 (en) | Antiproliferative compounds, and their pharmaceutical compositions and uses | |
| JP2025508122A5 (https=) | ||
| JP7539892B2 (ja) | 癌疾患の処置のためのエンドリボヌクレアーゼのイノシトール要求酵素ｉ（ｉｒｅｉアルファ）の阻害剤としてのピリド－ピリミジノン化合物及びプテリジノン化合物 | |
| JP2025134754A (ja) | Ｅｇｆｒ変異を有するがんを処置するためのアミノ置換ヘテロ環類 | |
| BR112020008839A2 (pt) | moduladores da via de estresse integrada | |
| JP2020504139A5 (https=) | ||
| TW201819386A (zh) | Shp2磷酸酶抑制劑及其使用方法 | |
| RU2008146759A (ru) | Производные дигидропиразолопиримидинона | |
| JP2017513893A5 (https=) | ||
| JP7611154B2 (ja) | ピリド－ピリミジニル化合物及び使用の方法 | |
| JP2015523390A5 (https=) | ||
| JP2010535201A (ja) | 抗癌治療としての抗有糸分裂薬およびオーロラキナーゼ阻害薬 | |
| CA2576269A1 (en) | Combinations for the treatment of diseases involving cell proliferation | |
| EA031573B1 (ru) | N-азаспироциклоалканзамещенные n-гетероарильные соединения и композиции для ингибирования активности shp2 | |
| CN107864625A (zh) | 含有取代的2,3‑二氢咪唑并[1,2‑c]喹唑啉的组合产品 | |
| CA2942636A1 (en) | Macrocylic pyrimidine derivatives | |
| KR20130069603A (ko) | 종양 및 섬유증 질환 치료에서의 신규 병용 치료 | |
| JP2016509056A5 (https=) | ||
| JP2015536994A5 (https=) | ||
| CN110475567A (zh) | 抗癌组合疗法 | |
| JP2018501209A5 (https=) |